Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
|
Medarex, Inc.http://www.medarex.com Medarex, Princeton NJ, United States of America. Medarex is an integrated monoclonal antibody-based company with antibody discovery, development and manufacturing capabilities. Utilizing its HuMAb-Mouse(TM) system, Medarex has the ability to make Ticker - Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338Wednesday 27th of May 2009 8:00BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
 Browse other news from this organisation: Medarex, Inc. Related Web-Links(If any, Generated Automatically)Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
